Trademark: 78359775
Word
SEPPRO
Status
Registered
Status Code
800
Status Date
Tuesday, September 22, 2015
Serial Number
78359775
Registration Number
3007344
Registration Date
Tuesday, October 18, 2005
Mark Type
4000
Filing Date
Thursday, January 29, 2004
Published for Opposition
Tuesday, July 26, 2005

Trademark Owner History

Classifications
1 Reagents for fractionating target proteins from complex biological fluids, such as plasma, serum, CSF, urine or other tissue or cellular sources, and the subsequent chemical analysis of compounds physiologically associated with abundant proteins including proteins, peptides, fatty acids, hormones, glycosylation states, phosphorylation states, etc; Reagents for diagnosis of diseases associated with albumin, IgG, Fibrinogen, Transferrin, IgA, IgM, a2-Macroglobulin, a1-Acid Glycoprotein, a1-Antitrypsin, Haptoglobin, High Density Lipoproteins, Complement C3; Immunoaffinity reagents for developing chemical markers that indicate the presence of disease states associated with albumin, IgG, Fibrinogen, Transferrin, IgA, IgM, a2-Macroglobulin, a1-Acid Glycoprotein, a1-Antitrypsin, Haptoglobin, High Density Lipoproteins, Complement C3; Reagents for determining biological targets for drugs, namely determining biological processes that are susceptible to being affected by drugs in order that the drugs may alleviate disease states and conditions related to albumin, IgG, Fibrinogen, Transferrin, IgA, IgM, a2-Macroglobulin, a1-Acid Glycoprotein, a1-Antitrypsin, Haptoglobin, High Density Lipoproteins, Complement C3 and associated compounds in humans and animals; Reagents for determining protein and peptide sequences for the purposes of identifying protein or peptide drug targets associated with albumin, IgG, Fibrinogen, Transferrin, IgA, IgM, a2-Macroglobulin, a1-Acid Glycoprotein, a1-Antitrypsin, Haptoglobin, High Density Lipoproteins, Complement C3, all for research use
42 Product development, medical and laboratory research in the field of proteomics, namely the science, system, components, organization, function, and biomedical applications of separation of abundant proteins, especially, in the area of proteomics sample processing that permits highly selective separation of abundant proteins, such as albumin, IgG, Fibrinogen, Transferrin, IgA, IgM, a2-Macroglobulin, a1-Acid Glycoprotein, a1-Antitrypsin, Haptoglobin, High Density Lipoproteins, Complement C3; development of chemical markers that indicate the presence of disease states; determining biological targets for drugs, namely determining biological processes that are susceptible to being affected by drugs in order that the drugs may alleviate disease states and conditions in humans and animals; determining protein and peptide sequences for the purposes of identifying protein or peptide drug targets; developing methodologies relating to the previous services such as developing bioanalytical methods to increase sensitivity, specificity and throughput of identifying and characterizing biological substances such as protein, peptides, hormones, lipids, used as biomarkers for a diagnosis or as drug targets

Trademark Events
May 20, 2021
Applicant/Correspondence Changes (Non-Responsive) Entered
May 20, 2021
Teas Change Of Correspondence Received
May 20, 2021
Teas Change Of Domestic Representatives Address
May 20, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
May 20, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
May 20, 2021
Teas Change Of Owner Address Received
Oct 28, 2020
Automatic Update Of Assignment Of Ownership
Sep 22, 2015
Notice Of Acceptance Of Sec. 8 & 9 - E-Mailed
Sep 22, 2015
Registered And Renewed (First Renewal - 10 Yrs)
Sep 22, 2015
Registered - Sec. 8 (10-Yr) Accepted/Sec. 9 Granted
Sep 22, 2015
Case Assigned To Post Registration Paralegal
Aug 24, 2015
Teas Section 8 & 9 Received
Aug 24, 2015
Teas Change Of Correspondence Received
Apr 21, 2012
Notice Of Acceptance Of Sec. 8 & 15 - E-Mailed
Apr 21, 2012
Registered - Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.
Apr 21, 2012
Case Assigned To Post Registration Paralegal
Apr 9, 2012
Teas Section 8 & 15 Received
Oct 4, 2011
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 4, 2011
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Sep 14, 2011
Assignment Of Ownership Not Updated Automatically
Mar 11, 2009
Automatic Update Of Assignment Of Ownership
Oct 18, 2005
Registered-Principal Register
Jul 26, 2005
Published For Opposition
Jul 6, 2005
Notice Of Publication
May 26, 2005
Law Office Publication Review Completed
May 23, 2005
Assigned To Lie
May 13, 2005
Approved For Pub - Principal Register
May 13, 2005
Examiners Amendment E-Mailed
May 13, 2005
Examiners Amendment -Written
May 11, 2005
Previous Allowance Count Withdrawn
Apr 22, 2005
Withdrawn Before Publication
Jan 27, 2005
Law Office Publication Review Completed
Jan 25, 2005
Assigned To Lie
Jan 11, 2005
Approved For Pub - Principal Register
Jan 10, 2005
Examiners Amendment E-Mailed
Jan 10, 2005
Examiners Amendment -Written
Dec 8, 2004
Amendment From Applicant Entered
Dec 1, 2004
Correspondence Received In Law Office
Dec 1, 2004
Teas Response To Office Action Received
Aug 26, 2004
Non-Final Action E-Mailed
Aug 20, 2004
Assigned To Examiner
Feb 9, 2004
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24